Related Experiment Video
Updated: Dec 12, 2025

Label-free Single Molecule Detection Using Microtoroid Optical Resonators
Published on: December 29, 2015
Structural Insights into TOR Signaling
Lucas Tafur1, Jennifer Kefauver1, Robbie Loewith1,2
1Department of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, Switzerland.
Abstract:
The Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cellular homeostasis and orchestrate the cellular responses to diverse environmental challenges. Interest in understanding TOR signaling is further motivated by observations that link aberrant TOR signaling to a variety of diseases, ranging from epilepsy to cancer. In the last few years, driven in large part by recent advances in cryo-electron microscopy, there has been an explosion of available structures of (m)TORC1 and its regulators, as well as several (m)TORC2 structures, derived from both yeast and mammals. In this review, we highlight and summarize the main findings from these reports and discuss both the fascinating and unexpected molecular biology revealed and how this knowledge will potentially contribute to new therapeutic strategies to manipulate signaling through these clinically relevant pathways.
Insights
The Target of Rapamycin (TOR) pathway regulates cell growth and metabolism. Recent structural studies reveal its molecular mechanisms, offering potential for new disease therapies.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The Target of Rapamycin (TOR) is a crucial serine/threonine kinase controlling cellular growth and metabolism.
- TOR functions in two complexes, TORC1 and TORC2, vital for cellular homeostasis and environmental response.
- Dysregulated TOR signaling is implicated in diseases like epilepsy and cancer.
Purpose of the Study:
- To review recent structural findings of (m)TORC1 and (m)TORC2 complexes.
- To discuss the revealed molecular biology of TOR signaling.
- To explore therapeutic strategies targeting TOR pathways.
Main Methods:
- Cryo-electron microscopy (cryo-EM) advancements.
- Analysis of published structural data for (m)TORC1 and (m)TORC2 from yeast and mammals.
- Literature review and synthesis of findings.
Main Results:
- An abundance of new (m)TORC1 and (m)TORC2 structures has become available.
- These structures illuminate the molecular mechanisms of TOR regulation and function.
- Unexpected molecular insights into TOR signaling have been uncovered.
Conclusions:
- Recent structural biology has significantly advanced our understanding of TOR complexes.
- This knowledge provides a foundation for developing novel therapeutic interventions.
- Targeting TOR signaling holds promise for treating various diseases.
More Related Videos
Related Concept Videos
Signal Transduction: Overview
Typically, signal transduction involves three...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Types of Signaling Molecules
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
IP3/DAG Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

